Therapy and survival after recurrence of Ewing's tumors: The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997

Gaetano Bacci; S. Ferrari; A. Longhi; D. Donati; M. De Paolis; C. Forni; M. Versari; E. Setola; A. Briccoli; E. Barbieri

doi:10.1093/annonc/mdg457

Therapy and survival after recurrence of Ewing's tumors: The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997

Gaetano Bacci, S. Ferrari, A. Longhi, D. Donati, M. De Paolis, C. Forni, M. Versari, E. Setola, A. Briccoli, E. Barbieri

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Many papers have reported the results achieved with combined therapy for Ewing's tumors, but little is known about the treatment and outcome of those 30-40% of patients who relapse. Patients and methods: In a retrospective study, we evaluated 195 patients with Ewing's tumors treated at our institution from 1979 to 1997 with chemotherapy, radiotherapy, surgery or combined therapies after recurrence. Results: A second complete remission was achieved in only 26 patients (13.3%); 12 relapsed again and died of the tumor. The 5-year post-relapse event-free survival and overall survival were 9.7% and 13.8%, respectively; both of which were significantly better for patients who had relapsed ≥2 years after the beginning of the first treatment (14.3% versus 2.5%; P

Original language	English
Pages (from-to)	1654-1659
Number of pages	6
Journal	Annals of Oncology
Volume	14
Issue number	11
DOIs	https://doi.org/10.1093/annonc/mdg457
Publication status	Published - Nov 2003

Keywords

Ewing's sarcoma
Outcome
Relapse
Treatment

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1093/annonc/mdg457

Fingerprint Dive into the research topics of 'Therapy and survival after recurrence of Ewing's tumors: The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997'. Together they form a unique fingerprint.

Cite this

Bacci, G., Ferrari, S., Longhi, A., Donati, D., De Paolis, M., Forni, C., Versari, M., Setola, E., Briccoli, A., & Barbieri, E. (2003). Therapy and survival after recurrence of Ewing's tumors: The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Annals of Oncology, 14(11), 1654-1659. https://doi.org/10.1093/annonc/mdg457

Therapy and survival after recurrence of Ewing's tumors : The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. / Bacci, Gaetano; Ferrari, S.; Longhi, A.; Donati, D.; De Paolis, M.; Forni, C.; Versari, M.; Setola, E.; Briccoli, A.; Barbieri, E.

In: Annals of Oncology, Vol. 14, No. 11, 11.2003, p. 1654-1659.

Research output: Contribution to journal › Article › peer-review

Bacci, G, Ferrari, S, Longhi, A , Donati, D, De Paolis, M, Forni, C, Versari, M, Setola, E, Briccoli, A & Barbieri, E 2003, 'Therapy and survival after recurrence of Ewing's tumors: The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997', Annals of Oncology, vol. 14, no. 11, pp. 1654-1659. https://doi.org/10.1093/annonc/mdg457

Bacci, Gaetano ; Ferrari, S. ; Longhi, A. ; Donati, D. ; De Paolis, M. ; Forni, C. ; Versari, M. ; Setola, E. ; Briccoli, A. ; Barbieri, E. / Therapy and survival after recurrence of Ewing's tumors : The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. In: Annals of Oncology. 2003 ; Vol. 14, No. 11. pp. 1654-1659.

@article{feed44ceea8c4047a9c98550d28c0249,

title = "Therapy and survival after recurrence of Ewing's tumors: The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997",

abstract = "Background: Many papers have reported the results achieved with combined therapy for Ewing's tumors, but little is known about the treatment and outcome of those 30-40% of patients who relapse. Patients and methods: In a retrospective study, we evaluated 195 patients with Ewing's tumors treated at our institution from 1979 to 1997 with chemotherapy, radiotherapy, surgery or combined therapies after recurrence. Results: A second complete remission was achieved in only 26 patients (13.3%); 12 relapsed again and died of the tumor. The 5-year post-relapse event-free survival and overall survival were 9.7% and 13.8%, respectively; both of which were significantly better for patients who had relapsed ≥2 years after the beginning of the first treatment (14.3% versus 2.5%; P ",

keywords = "Ewing's sarcoma, Outcome, Relapse, Treatment",

author = "Gaetano Bacci and S. Ferrari and A. Longhi and D. Donati and {De Paolis}, M. and C. Forni and M. Versari and E. Setola and A. Briccoli and E. Barbieri",

year = "2003",

month = nov,

doi = "10.1093/annonc/mdg457",

language = "English",

volume = "14",

pages = "1654--1659",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "11",

}

TY - JOUR

T1 - Therapy and survival after recurrence of Ewing's tumors

T2 - The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997

AU - Bacci, Gaetano

AU - Ferrari, S.

AU - Longhi, A.

AU - Donati, D.

AU - De Paolis, M.

AU - Forni, C.

AU - Versari, M.

AU - Setola, E.

AU - Briccoli, A.

AU - Barbieri, E.

PY - 2003/11

Y1 - 2003/11

N2 - Background: Many papers have reported the results achieved with combined therapy for Ewing's tumors, but little is known about the treatment and outcome of those 30-40% of patients who relapse. Patients and methods: In a retrospective study, we evaluated 195 patients with Ewing's tumors treated at our institution from 1979 to 1997 with chemotherapy, radiotherapy, surgery or combined therapies after recurrence. Results: A second complete remission was achieved in only 26 patients (13.3%); 12 relapsed again and died of the tumor. The 5-year post-relapse event-free survival and overall survival were 9.7% and 13.8%, respectively; both of which were significantly better for patients who had relapsed ≥2 years after the beginning of the first treatment (14.3% versus 2.5%; P

AB - Background: Many papers have reported the results achieved with combined therapy for Ewing's tumors, but little is known about the treatment and outcome of those 30-40% of patients who relapse. Patients and methods: In a retrospective study, we evaluated 195 patients with Ewing's tumors treated at our institution from 1979 to 1997 with chemotherapy, radiotherapy, surgery or combined therapies after recurrence. Results: A second complete remission was achieved in only 26 patients (13.3%); 12 relapsed again and died of the tumor. The 5-year post-relapse event-free survival and overall survival were 9.7% and 13.8%, respectively; both of which were significantly better for patients who had relapsed ≥2 years after the beginning of the first treatment (14.3% versus 2.5%; P

KW - Ewing's sarcoma

KW - Outcome

KW - Relapse

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=10744220751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744220751&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdg457

DO - 10.1093/annonc/mdg457

M3 - Article

C2 - 14581274

AN - SCOPUS:10744220751

VL - 14

SP - 1654

EP - 1659

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 11

ER -